Objective
To evaluate the long-term efficacy of mirabegron add-on therapy in patients with spinal cord injury (SCI) based on an urodynamic study.
Methods
This retrospective study involved a chart audit of individuals with SCI who underwent two consecutive urodynamic studies between April 1, 2015 and April 1, 2018. After adding 50 mg of mirabegron once a day to the pre-existing antimuscarinic therapy for a period of, at least 6 months, the following variables were analyzed: change in cystometric capacity, change in bladder compliance, change in maximal detrusor pressure, change in reflex volume, and presence of significant leakage during filling cystometry.
Results
A total of 31 participants with a mean age of 41±15 years were included in the analysis. A significant increase in cystometric capacity (mean, 362 to 424 mL; p=0.03), reflex volume (mean, 251 to 329 mL; p=0.02), and bladder compliance (median, 12 to 18 mL/cmH2O; p=0.04) was observed. The presence of leakage during filling cystometry was significantly reduced (29% to 10%; p=0.03). Likewise, a non-significant decrease in the change in maximal detrusor pressure was observed (mean, 31 to 27 cmH2O; p=0.39).
Conclusion
Adding mirabegron to conventional antimuscarinics further improved urodynamic parameters in patients with chronic SCI, and sustained efficacy was observed in long-term use.

Citations

• Mirabegron in the treatment of neurogenic detrusor overactivity: pharmacological and clinical aspects
  Igor V. Kuzmin
  Urology reports (St. - Petersburg).2025; 15(1): 51.     CrossRef
• Drug Repurposing for Spinal Cord Injury: Progress Towards Therapeutic Intervention for Primary Factors and Secondary Complications
  Lahanya Guha, Hemant Kumar
  Pharmaceutical Medicine.2023; 37(6): 463.     CrossRef
• Management of the Devastated Female Urethra
  Anne Shirley Hoselton, Paige Kuhlmann, Ramy Goueli
  Current Bladder Dysfunction Reports.2023; 18(4): 293.     CrossRef
• Bowel and Bladder Care in Patients With Spinal Cord Injury
  Eren O. Kuris, Daniel Alsoof, Camilo Osorio, Alan H. Daniels
  Journal of the American Academy of Orthopaedic Surgeons.2022; 30(6): 263.     CrossRef
• Urological Care After Spinal Cord Injury
  Gamal Ghoniem, Dena Moskowitz, Catherine Nguyen
  Current Physical Medicine and Rehabilitation Reports.2022; 10(2): 89.     CrossRef
• Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: a systematic review
  Yesim Akkoc
  Spinal Cord.2022; 60(10): 854.     CrossRef
• Urogenital dysfunction following neurotrauma
  Udit Saraf, Anand Kumar A, Jalesh N. Panicker
  Current Opinion in Neurology.2022; 35(6): 753.     CrossRef